Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GX-E2 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions

Healthy

Interventions

DRUG

GX-E2

Investigational drug(GX-E2 or Placebo) will be administered to healthy volunteers by the intravenous route.

DRUG

GX-E2

Investigational drug(GX-E2 or Placebo) will be administered to healthy volunteers by the intravenous route.

Trial Locations (1)

Seoul National University Hospital, Seoul